Yes kbear, this ONTY had got my attention when I first read that sth cross report in May and started to follow their story since. To me, it's link with PRR is much tighter and way more important than that with DNDN since they literally use the same technology.
And so far, ONTY has been performing well in terms of pineline progress and also its latest Q3 result.
If DNDN's Provenge success means 30% of the success rate for Cvac, I would imagine ONTY's Stimuvax success would mean double or even tripple effect for us.
So I would keep a close eye in 2012.
btw: it's been a while since last saw you on the PRR thread kbear, keep up the good post, it's really quiet lately.
Yes kbear, this ONTY had got my attention when I first read that...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.015(3.95%) |
Mkt cap ! $530.2M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 36.5¢ | $413.2K | 1.123M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103704 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 68352 | 2 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |